EASL Clinical Practice Guidelines: Vascular diseases of the liver European Association For The Study Of The Liver Journal of hepatology 64 (1), 179-202, 2016 | 725 | 2016 |
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity T Lisman, TN Bongers, J Adelmeijer, HLA Janssen, MPM de Maat, ... Hepatology 44 (1), 53-61, 2006 | 705 | 2006 |
Etiology, management, and outcome of the Budd-Chiari syndrome SD Murad, A Plessier, M Hernandez-Guerra, F Fabris, CE Eapen, ... Annals of internal medicine 151 (3), 167-175, 2009 | 626 | 2009 |
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma JC Chambers, W Zhang, J Sehmi, X Li, MN Wass, P Van der Harst, ... Nature genetics 43 (11), 1131-1138, 2011 | 620 | 2011 |
Von Willebrand’s disease FWG Leebeek, JCJ Eikenboom New England Journal of Medicine 375 (21), 2067-2080, 2016 | 549 | 2016 |
Coagulation disorders after traumatic brain injury BS Harhangi, EJO Kompanje, FWG Leebeek, AIR Maas Acta neurochirurgica 150, 165-175, 2008 | 497 | 2008 |
Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study M Kavousi, S Elias-Smale, JHW Rutten, MJG Leening, R Vliegenthart, ... Annals of internal medicine 156 (6), 438-444, 2012 | 447 | 2012 |
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis JH Smalberg, LR Arends, DC Valla, JJ Kiladjian, HLA Janssen, ... Blood, The Journal of the American Society of Hematology 120 (25), 4921-4928, 2012 | 424 | 2012 |
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome … NL Smith, MH Chen, A Dehghan, DP Strachan, S Basu, N Soranzo, ... Circulation 121 (12), 1382-1392, 2010 | 408 | 2010 |
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study EM Koehler, EPC Plompen, JNL Schouten, BE Hansen, SD Murad, ... Hepatology 63 (1), 138-147, 2016 | 361 | 2016 |
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis T Lisman, FWG Leebeek, LO Mosnier, BN Bouma, JCM Meijers, ... Gastroenterology 121 (1), 131-139, 2001 | 358 | 2001 |
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B W Miesbach, K Meijer, M Coppens, P Kampmann, R Klamroth, ... Blood, The Journal of the American Society of Hematology 131 (9), 1022-1031, 2018 | 325 | 2018 |
High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability TN Bongers, MPM de Maat, MLPJ van Goor, V Bhagwanbali, ... Stroke 37 (11), 2672-2677, 2006 | 299 | 2006 |
Haemostatic abnormalities in patients with liver disease T Lisman, FWG Leebeek, PG de Groot Journal of hepatology 37 (2), 280-287, 2002 | 290 | 2002 |
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A CL Eckhardt, AS Van Velzen, M Peters, J Astermark, PP Brons, ... Blood, The Journal of the American Society of Hematology 122 (11), 1954-1962, 2013 | 259 | 2013 |
The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study M Nijkeuter, M Söhne, LW Tick, PW Kamphuisen, MHH Kramer, ... Chest 131 (2), 517-523, 2007 | 256 | 2007 |
Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis A De Gottardi, J Trebicka, C Klinger, A Plessier, S Seijo, B Terziroli, ... Liver International 37 (5), 694-699, 2017 | 244 | 2017 |
Emerging concepts in immune thrombocytopenia M Swinkels, M Rijkers, J Voorberg, G Vidarsson, FWG Leebeek, ... Frontiers in immunology 9, 880, 2018 | 237 | 2018 |
Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment T Lisman, FWG Leebeek Digestive surgery 24 (4), 250-258, 2007 | 231 | 2007 |
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease NT Connell, VH Flood, R Brignardello-Petersen, R Abdul-Kadir, ... Blood advances 5 (1), 301-325, 2021 | 229 | 2021 |